文献速递遗传性与小管间质肾病

CLCN5基因变异位点与类型影响Dent病1型表型

The Site and Type of CLCN5 Genetic Variation Impact the Resulting Dent Disease-1 Phenotype.
PubMed 文献 · Kidney Int Rep · 2023-03-23

回顾性分析121个家系162例基因确诊的Dent病1型患者,其中截短变异110例、非截短变异52例。截短变异组结石事件更早发生且白蛋白排泄率更高,终生结石事件与慢性肾脏病进展正相关;肾功能衰竭相关变异主要局限于截短变异。

要点

  • 截短变异患者结石事件发生更早,白蛋白排泄率高于非截短变异组。
  • 截短变异组终生结石事件与慢性肾脏病进展正相关。
  • 肾功能衰竭相关变异主要见于截短变异(13例中11例)。

核心结论

  • Dent病1型的临床表现包括肾结石风险和进展至肾功能衰竭,可能与ClC-5残余功能程度相关。

研究设计与样本

  • 回顾性研究纳入来自121个不同家系的162例基因确诊Dent病1型患者,鉴定出82种不同致病性变异(按美国医学遗传学与基因组学学会指南验证)。
  • 110例患者携带51种不同的截短变异(无义、移码、大片段缺失和经典剪接),52例患者携带31种不同的非截短变异(错义、框内、非经典剪接和终止密码子丢失)。
  • 本队列发现16种新描述的致病性变异。

主要发现

  • 截短变异组患者终生结石事件与慢性肾脏病进展呈正相关。
  • 截短变异组患者结石事件发生更早,且白蛋白排泄率高于非截短变异组。
  • 截短变异组与非截短变异组在肾钙质沉着症发生年龄和慢性肾脏病进展方面无差异。
  • 非截短变异中26/31(84%)聚集于编码电压ClC结构域的中间外显子,而截短变异分散于整个蛋白。
  • 与肾功能衰竭相关的变异局限于截短变异(13例中11例),另2例携带一种先前显示可显著降低ClC-5功能活性的错义变异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Dent disease is an X-linked recessive disorder associated with low molecular weight proteinuria (LMWP), nephrocalcinosis, kidney stones, and kidney failure in the third to fifth decade of life. It consists of Dent disease 1 (DD1) (60% of patients) because of pathogenic variants in the CLCN5 gene and Dent disease 2 (DD2) with changes in OCRL. METHODS: Retrospective review of 162 patients from 121 different families with genetically confirmed DD1 (82 different pathogenic variants validated using American College of Medical Genetics [ACMG] guidelines). Clinical and genetic factors were compared using observational statistics. RESULTS: A total of 110 patients had 51 different truncating (nonsense, frameshifting, large deletions, and canonical splicing) variants, whereas 52 patients had 31 different nontruncating (missense, in-frame, noncanonical splicing, and stop-loss) changes. Sixteen newly described pathogenic variants were found in our cohort. Among patients with truncating variants, lifetime stone events positively correlated with chronic kidney disease (CKD) evolution. Patients with truncating changes also experienced stone events earlier in life and manifested a higher albumin excretion rate than the nontruncating group. Nevertheless, neither age of nephrocalcinosis nor CKD progression varied between the truncating versus nontruncating patients. A large majority of nontruncating changes (26/31; 84%) were clustered in the middle exons that encode the voltage ClC domain whereas truncating changes were spread across the protein. Variants associated with kidney failure were restricted to truncating (11/13 cases), plus a single missense variant previously shown to markedly reduce ClC-5 functional activity that was found in the other 2 individuals. CONCLUSION: DD1 manifestations, including the risk of kidney stones and progression to kidney failure, may relate to the degree of residual ClC-5 function.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Arnous MG, Arroyo J, Cogal AG, et al. The Site and Type of CLCN5 Genetic Variation Impact the Resulting Dent Disease-1 Phenotype. Kidney Int Rep. 2023. PMID: 37284679. doi:10.1016/j.ekir.2023.03.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。